GSK Targeted By Chinese Officials Over Overpriced Drugs And Bribery
China's anti-corruption probes are going after foreign companies that are marking up prices.
Chinese Police Charge Former GSK China Head With Bribery
It is the biggest corruption scandal to hit a foreign company in China since the Rio Tinto affair in 2009.
Novartis, Glaxo Swap $20B In Assets
The deal's goal is to bolster best lines and exit weaker ones, as the sector contends with health care spending cuts and generic competition.
Novartis Overhauls Portfolio Through Deals With GSK And Eli Lilly
In February, Novartis had acquired CoStim Pharmaceuticals to broaden its cancer immunotherapy research program.
AstraZeneca Cancer Drugs Seen As Draw For Pfizer
A deal could benefit Pfizer as it seeks to build up its cancer franchise, and acquiring AstraZeneca could bring cost savings.
GlaxoSmithKline Under Criminal Investigation In Poland
In the past, GSK has faced charges of corruption in China and Iraq. In 2012, it paid $3 billion to the FDA after pleading guilty for malpractice.
Is The Risk Of Corruption Worth Doing Business In China?
Many companies are shying away from doing business in the world's second-largest economy, while others find corruption unavoidable.
Pharmaceutical Company Discontinues Lifesaving Cancer Drug Due To Disappointing Profits
One man dies after being denied access to an experimental cancer drug.
GlaxoSmithKline To Increase Stake In India Unit For $1.2B
The deal, involving GSK's pharma unit, is the company's second large investment in an Indian subsidiary this year.
The Human Brain Project's Ambitious Mission
The Human Brain project is hosting its 2013 summit from Oct. 7 to Oct. 11, 2013.
Why Pfizer And Big Pharma Keep Suing Generic Drugmakers In India
Lawsuits buy big pharma more time in India, but it's the drug development divisions that will ultimately lose out.
Yet Another Western Pharmaceutical Company Is Having Problems In China
Baxter International admitted to expense violations at a joint venture in China.
China: Pharmaceutical Companies Probe To Continue
Following the investigation of GlaxoSmithKline other foreign pharmaceutical firms could be probed for corruption.
Glaxo Says Execs May Have Broken Chinese Law
Pharmaceutical giant admits that high-level employees in China "appear to have acted outside of our processes and controls."
GSK To Respond To Chinese Bribery Allegations Wednesday
The British pharmaceutical firm will detail its response to allegations from Chinese authorities when it gives quarterly results.
GlaxoSmithKline Spent Nearly $500M In Bribes In China: Govt Agency
China says GlaxoSmithKline acted like a 'Godfather,' criminally routing millions of dollars in bribes to boost its sales in the country.
Glaxo Probing China Botox Sales Methods
GlaxoSmithKline said on Monday that it is probing whether its employees bribed local doctors to sell Botox in China.
China Detains GlaxoSmithKline Workers In Corruption Probe
Chinese police probe the British pharmaceutical giant after its internal investigation finds no evidence of corruption.
Pages
Glaxo Found No China Bribery After 4-Month Investigation
After receiving allegations of bribery in its China operations, Glaxo launched an investigation but found no evidence suggesting corruption.
Pearl Therapeutics Acquired By AstraZeneca For $1.15B
British drug-maker AstraZeneca agreed to buy California's respiratory drug company Pearl Therapeutics for $1.15 billion.
Relax Restrictions On Diabetes Drug Avandia: FDA Panel
An FDA panel recommended relaxing tough safety restrictions on GlaxoSmithKline's diabetes drug Avandia.
Big Pharma: Declining Returns
The pharmaceutical industry is grappling with diminishing R&D productivity -- exemplified by a drop in revenue per new drug approval.
Pre-Market Movers
LinkedIn Corp, Starbucks Corp, Pan American Silver Corp, Alcatel Lucent, GlaxoSmithKline, Nokia Corp, Deutsche Bank and Weatherford International Ltd. are among the companies whose shares are moving in pre-market trading Friday.
Big Bets Aim To Jolt Heart Drug Sales Back To Life
Patent expiries mean annual sales of 15 different categories of heart drugs are set to fall by more than a quarter by 2017, from $83 billion in 2011 to $60 billion, according to consensus analyst forecasts compiled by Thomson Reuters Pharma.
London Olympics Drug Testing Aims To Cast Widest Net Of Any Games
More than 5,000 blood and urine samples will be tested for banned substances at this year's Olympics, more than any previous games.
Latest news
- MOST READ
- 1
- 2
- 3
- 4
- 5
EDITOR'S PICK